Accessibility: Skip TopNav
Figure 1.
Change in MDS-UPDRS scores from Baseline at Day 150 in all patients for whom CSF GluSph were available, patients with low baseline GluSph, and patients with high baseline GluSph
Format
JPEG
Quelle:
Gain Therapeutics, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein